Amgen (AMGN)

EBITDA Growth

10.84%

TTM · Period ending:

AMGN logo

AMGN EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported10.84%
AMGN TTM EBITDA YoY % (41.18% → 10.84%)
High-resolution chart · PNG

AMGN ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Amgen EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
11.2475%
6.5901%
8.017%
13.2706%
15.4615%
18.6337%
18.9827%
24.1985%
27.2336%
25.1721%
20.5079%
10.8402%
2.1316%
1.3375%
4.5936%
9.4096%
14.0663%
17.5407%
18.5089%
15.9453%
16.2534%
14.0059%
9.272%
16.8698%
19.7091%
23.1825%
28.4551%
8.746%
8.3454%
9.7249%
13.2005%
58.6415%
74.8383%
223.7535%
267.0117%
1,131.25%
2,168.0233%
159.4477%
457.3077%
-48.8584%
-131.9109%
67.8049%
171.8232%
321.9595%
402.809%
954.1667%
-366.1765%
-601.6949%
-1,877.7778%
14.2857%
-20.4678%
-47.7876%
-118.75%
-330.7692%
263.8298%
465%
41.1765%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.